Salesforce
CRM
Adobe
ADBE
Amazon
AMZN
Oracle
ORCL
Microsoft
MSFT
US Stock MarketDetailed Quotes
XBIOW Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com)
- 17.5400
- 0.00000.00%
Trading Jul 18 16:00 ET
0Market Cap0.00P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open17.5400Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares20.500052wk High0.00P/B0Float Cap1.120052wk Low--Dividend TTM0Shs Float23.1600Historical High--Div YieldTTM0.00%Amplitude0.0001Historical Low--Avg Price1Lot Size
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) News
4: Statement of changes in beneficial ownership of securities-Officer PARSLOW JAMES F
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dmitry Genkin(14.0%),CLS Therapeutics Ltd.(9.6%), etc.
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director Mizrahy Moshe
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 3: Initial statement of beneficial ownership of securities-Director Mizrahy Moshe
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Officer Lockshin Curtis
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer PARSLOW JAMES F
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director Kornberg Roger D.
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director Borisenko Grigory G.
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director Dastoor Firdaus J.
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director Callaway James Eric
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director VINOGRADOV ALEXEY ANDREEVICH
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities-Director Logal Adam
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Dmitry Genkin(13.0%),CLS Therapeutics Ltd.(9.6%), etc.
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | SC 13D: Statement of acquisition of beneficial ownership by individuals-CLS Therapeutics Ltd.(9.7%),Dmitry Genkin(9.7%), etc.
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities
Xenetic Biosciences Inc C/Wts 19/07/2024 (To Pur Com) | 4: Statement of changes in beneficial ownership of securities